These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 15730423)
21. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. Baudin E; Do Cao C; Cailleux AF; Leboulleux S; Travagli JP; Schlumberger M J Clin Endocrinol Metab; 2003 Mar; 88(3):1107-11. PubMed ID: 12629092 [TBL] [Abstract][Full Text] [Related]
22. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? Cailleux AF; Baudin E; Travagli JP; Ricard M; Schlumberger M J Clin Endocrinol Metab; 2000 Jan; 85(1):175-8. PubMed ID: 10634383 [TBL] [Abstract][Full Text] [Related]
23. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma. Lin JD; Kao PF; Chao TC Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241 [TBL] [Abstract][Full Text] [Related]
24. Thyroglobulin measurement vs iodine 131 total-body scan for follow-up of well-differentiated thyroid cancer. Aiello DP; Manni A Arch Intern Med; 1990 Feb; 150(2):437-9. PubMed ID: 2105703 [TBL] [Abstract][Full Text] [Related]
25. Surgery of thyroid cancer: twelve years' personal experience. Pareschi R; Mincione A; Destito D; Mola M; Righini S; Assi A; Dottorini M Acta Otorhinolaryngol Ital; 2004 Dec; 24(6):348-53. PubMed ID: 15952685 [TBL] [Abstract][Full Text] [Related]
28. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591 [TBL] [Abstract][Full Text] [Related]
29. Charcoal suspension tattoo localization for differentiated thyroid cancer recurrence. Hartl DM; Chami L; Al Ghuzlan A; Leboulleux S; Baudin E; Schlumberger M; Travagli JP Ann Surg Oncol; 2009 Sep; 16(9):2602-8. PubMed ID: 19551443 [TBL] [Abstract][Full Text] [Related]
30. Circulating thyroglobulin mRNA does not predict early and midterm recurrences in patients undergoing thyroidectomy for cancer. Lombardi CP; Bossola M; Princi P; Boscherini M; La Torre G; Raffaelli M; Traini E; Salvatori M; Pontecorvi A; Bellantone R Am J Surg; 2008 Sep; 196(3):326-32. PubMed ID: 18614150 [TBL] [Abstract][Full Text] [Related]
31. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer. Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858 [TBL] [Abstract][Full Text] [Related]
32. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer. Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922 [TBL] [Abstract][Full Text] [Related]
33. Critical evaluation of serum thyroglobulin levels and I-131 scans in post-therapy patients with differentiated thyroid carcinoma: concise communication. Echenique RL; Kasi L; Haynie TP; Glenn HJ; Samaan NA; Hill CS J Nucl Med; 1982 Mar; 23(3):235-40. PubMed ID: 7062137 [TBL] [Abstract][Full Text] [Related]
34. [Non-iodine-absorbing metastasis of differentiated thyroid cancer--therapeutic probe with 13-cis retinoic acid]. Kaniewski M; Czetwertyńska M; Godlewska P; Drac-Kaniewska J Wiad Lek; 2001; 54 Suppl 1():297-300. PubMed ID: 12182038 [TBL] [Abstract][Full Text] [Related]
35. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer. Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198 [TBL] [Abstract][Full Text] [Related]
36. Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine. Pacini F; Gasperi M; Fugazzola L; Ceccarelli C; Lippi F; Centoni R; Martino E; Pinchera A J Nucl Med; 1994 Sep; 35(9):1418-22. PubMed ID: 8071685 [TBL] [Abstract][Full Text] [Related]
37. [The value of serum thyroglobulin determination in the after-care of patients with differentiated thyroid neoplasms]. Hüfner M; Pollmann H; Grussendorf M; Schenk P Schweiz Med Wochenschr; 1980 Feb; 110(5):159-62. PubMed ID: 7361086 [TBL] [Abstract][Full Text] [Related]
38. Hürthle cell carcinoma: a clinicopathological study of thirteen cases. Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925 [TBL] [Abstract][Full Text] [Related]
39. Papillary and follicular thyroid carcinoma. Schlumberger MJ; Torlantano M Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Dec; 14(4):601-13. PubMed ID: 11289737 [TBL] [Abstract][Full Text] [Related]
40. [Value of the assay of thyroglobulin for postoperative surveillance of differentiated thyroid cancers]. Jaffiol C; Baldet L Ann Med Interne (Paris); 1984; 135(5):359-64. PubMed ID: 6486615 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]